Coronavirus disease 2019 (COVID-19) placed a strainon outpatient dermatology visits. Data collectedfrom the beginning of the pandemic indicates thatthe average number of patient visits and biopsies fellby 50% during March, 2020, and providers averagedthree days of practice per week. It is also estimatedthat this trend has continued for the duration of theepidemic [1]. Postponed elective surgeries and “nonurgent” visits contributed to a decline in outpatientvisits and to offset financial losses, the Departmentof Health and Human Services (HHS) is distributing$175 billion to hospitals and healthcare providers [2].The goal of our study was to characterize federaldirect aid to dermatologists and examinedistribution patterns for potential inequalities.
展开▼
